Goldenwell Biotech Inc

NEW
OTCPK:GWLL (USA)   Ordinary Shares
$ 0.90 (0%) 11:08 PM EST
At Loss
Market Cap:
$ 89.10M
Enterprise V:
$ 89.18M
Volume:
200.00
Avg Vol (2M):
1.23K
Trade In:
Volume:
200.00
At Loss
Avg Vol (2M):
1.23K

Business Description

Goldenwell Biotech Inc
NAICS : 456191 SIC : 5142
ISIN : US38138N1046

Share Class Description:

GWLL: Ordinary Shares
Description
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
Name Current Vs Industry Vs History
Cash-To-Debt
0.14
Equity-to-Asset
-19
Debt-to-Equity
-0.27
Debt-to-EBITDA
-0.36
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
33.1
3-Year EPS without NRI Growth Rate
53.6
Name Current Vs Industry Vs History
5-Day RSI
99.4
9-Day RSI
91.93
14-Day RSI
79.34
3-1 Month Momentum %
-48.18
6-1 Month Momentum %
-81.43
12-1 Month Momentum %
160

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.19
Quick Ratio
0.19
Cash Ratio
0.13

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROA %
-192.2
ROIC %
-74.48
3-Year ROIIC %
-872
ROC (Joel Greenblatt) %
-181.39
ROCE %
-326.03
Moat Score
2

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio without NRI
N/A
N/A
N/A
Price-to-Free-Cash-Flow
900
Price-to-Operating-Cash-Flow
900
EV-to-EBIT
-332.77
EV-to-EBITDA
-332.77
EV-to-FCF
-22295.5
Earnings Yield (Greenblatt) %
-0.3

Financials

GWLL's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GWLL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Goldenwell Biotech Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.002
Beta 8.217
3-Year Sharpe Ratio 0.59
3-Year Sortino Ratio 15.7
Volatility % 3417.72
14-Day RSI 79.34
14-Day ATR ($) 0.032475
20-Day SMA ($) 0.596
12-1 Month Momentum % 160
52-Week Range ($) 0.2 - 10
Shares Outstanding (Mil) 99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Goldenwell Biotech Inc Filings

Filing Date Document Date Form
No Filing Data

Goldenwell Biotech Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Goldenwell Biotech Inc Frequently Asked Questions

What is Goldenwell Biotech Inc(GWLL)'s stock price today?
The current price of GWLL is $0.90. The 52 week high of GWLL is $10.00 and 52 week low is $0.20.
When is next earnings date of Goldenwell Biotech Inc(GWLL)?
The next earnings date of Goldenwell Biotech Inc(GWLL) is .
Does Goldenwell Biotech Inc(GWLL) pay dividends? If so, how much?
Goldenwell Biotech Inc(GWLL) does not pay dividend.

Guru Commentaries on OTCPK:GWLL

No articles.

Press Release

Subject Date
No Press Release

Articles on Goldenwell Biotech Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1